| |
|
Form Serial Number: |
DA20250624E00388
|
| 1.
Date of relevant event: |
19/06/2025
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
06681 |
| 4.
Name of listed corporation: |
BrainAurora Medical Technology Ltd. - B |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
1,266,278,000 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Wang |
| (Other names) |
Xiaoyi |
|
|
|
| 10.
Name of director (Chinese): |
王晓怡 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1706 | Miscellaneous
Notice filed because you ceased to be a director or chief executive of the listed corporation |
|
|
|
|
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 210,901,000 | 16.66 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 210,901,000 | 16.66 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2305 | Beneficiary of a trust (other than a discretionary interest) |
| |
| 2201 | Interest of corporation controlled by you |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Wispirits Limited | Sea Meadow House, P.O. Box 116, Road Town, Tortola, British Virgin Islands (British Virgin Islands) | Wang Xiaoyi | 100.00 | Y | |
| Wiseforward Limited | Sea Meadow House, P.O. Box 116, Road Town, Tortola, British Virgin Islands (British Virgin Islands) | Wang Xiaoyi | 100.00 | Y | |
| Neurobright Limited | Sea Meadow House, P.O. Box 116, Road Town, Tortola, British Virgin Islands (British Virgin Islands) | Wang Xiaoyi | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Box 27: Wisdomspirit Holding Limited, a wholly owned entity of Trident Trust Company (HK) Limited, is the trustee of the trust established pursuant to the Pre-IPO Share Award Scheme of which Dr. Wang is a beneficiary. Box 30: Neurobright Limited ("NL") was owned by Dr. Wang (approx. 32.82%) and each of the shareholders of NL entered into proxy arrangement with Dr. Wang resp., to allow him to have control over the entire voting power thereof. As such NL is a controlled corporation of Dr. Wang.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
24/06/2025
(dd/mm/yyyy)
|
| |